Quin C1
CAS No. 786706-21-6
Quin C1( —— )
Catalog No. M35017 CAS No. 786706-21-6
Quin C1 is a selective and potent formylpeptide receptor 2 (FPR2/ALX) agonist with anti-inflammatory activity, inhibits neutrophil and lymphocyte production in BALF, and reduces the expression of TNF-α, IL-1β, KC, and TGF-β1.Quin C1 is used in the study of lung injury.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 122 | In Stock |
|
| 10MG | 183 | In Stock |
|
| 25MG | 320 | In Stock |
|
| 50MG | 437 | In Stock |
|
| 100MG | 603 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameQuin C1
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuin C1 is a selective and potent formylpeptide receptor 2 (FPR2/ALX) agonist with anti-inflammatory activity, inhibits neutrophil and lymphocyte production in BALF, and reduces the expression of TNF-α, IL-1β, KC, and TGF-β1.Quin C1 is used in the study of lung injury.
-
DescriptionQuin C1 is a highly specific and potent agonist for formyl peptide receptor 2 (FPR2/ALX). Quin-C1 significantly reduces the neutrophil and lymphocyte counts in BALF, diminishes expression of TNF-α, IL-1β, KC, and TGF-β1, and decreases collagen deposition in lung tissue. Quin C1 has the potential for the research of lung injury.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number786706-21-6
-
Formula Weight445.51
-
Molecular FormulaC26H27N3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (224.46 mM; Ultrasonic )
-
SMILESCCCCOc1ccc(cc1)C(=O)NN1C(Nc2ccccc2C1=O)c1ccc(OC)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. He M, et al. Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury. Acta Pharmacol Sin. 2011;32(5):601-610.?
molnova catalog
related products
-
Interleukin-1β Conve...
Interleukin-1β Convertase Substrate
-
PLH1215
PLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.
-
Dehydroborapetoside ...
Dehydroborapetoside B is a natural product for research related to life sciences.
Cart
sales@molnova.com